2.10pm - 3.10pm
Sponsor Session
LECTURE: Ocular surface disease untangled - Thea Pharmaceuticals
CPD ref: C-101897
Description: This lecture will cover the pathophysiology of ocular surface disease caused by dry eye including inflammation mechanisms and the influence of medications. With reference to the TFOS DEWS II report the lecturer will discuss the importance of investigative techniques and conclude with sharing pearls of practice on deciding treatment.
Target audience: Optometrist, Dispensing optician, Contact lens optician
Domains and learning outcomes
Clinical practice
Practitioners will have an understanding about the pathophysiology of ocular surface disease and how these factors influence the management of dry eye. (s.5)
Practitioners will have an understanding of the homeostatic mechanisms of the anterior eye in relation to patient symptoms and signs as outlined in the TFOS DEWS II Report (s.5)
Practitioners will be able to make appropriate decisions in the management of dry eye disease in contact lens wearers (s.5)
Communication
Practitioners will be an understanding on risk factors and pathophysiology such as general health, medication, lifestyle, etc and be able to communicate this to the patient and outline a management plan for dry eye disease. (s.2)